ILS scientists help FDA evaluate the genotoxic potential of over 150 electronic nicotine delivery systems (ENDS) flavorings using cell-based and [...]
ILS Toxicology Study Director, Melanie Foster, DABT presented the following poster titled, "So You Want To Do Regulatory Developmental Neurotoxicology [...]
ILS Director of Toxicology, Cheryl Hobbs, PhD, Study Director/Health and Safety Officer, Michael A. Streicker, LATG, and Analytical Chemistry Study [...]
The 9th Annual ASCCT meeting will be taking place virtually October 20-22. The meeting will feature plenary speakers, panel discussions, oral and poster presentations drawn from submitted abstracts, and opportunities for early-career scientists through a mentoring session and poster awards.
Dr. Stephanie Smith-Roe of the National Toxicology Program will present results of a collaborative effort between ILS, TwinStrand Biosciences, and the NTP at this year’s virtual Environmental Mutagenesis and Genomics Society’s annual meeting. ILS scientists Cheryl A. Hobbs, Ph.D., Leslie Recio, Ph.D., DABT, Michael A. Streicker, LATG, and Miriam V. Rivas, Ph.D. are co-authors of the presented work.
ILS is participating in the 60th annual Society for Birth Defects Research & Prevention Meeting, which is taking place virtually June 29-July 2, 2020.
60th annual Society for Birth Defects Research & Prevention Virtual Meeting